Drug profile · INN
dopamine
dopamine is a beta-1 adrenergic receptor agonist.
Drug details — dopamine
- Class
- —
- Route
- —
- Patents
- 8
- Programs
- 2
- Data quality
- 0.70
Quick answer
dopamine is a beta-1 adrenergic receptor agonist.
Key facts
Mechanism of action
Beta-1 adrenergic receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
CA 3142348
INHIBITEURS DE DOPAMINE-B-HYDROXYLASE
granted -
WO 2020246903
INHIBITEURS DE DOPAMINE-B-HYDROXYLASE
granted -
AU 2018379646
Dopamine-B-hydroxylase inhibitors
granted -
CA 3103212
FORMULATIONS COMPRENANT DES INHIBITEURS DE LA DOPAMINE-S-HYDROXYLASE ET LEURS PROCEDES DE PREPARATION
granted -
US 2019337950
BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS
granted -
CA 3082337
INHIBITEURS DE DOPAMINE-B-HYDROXYLASE
granted -
EP 1303278
KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN
expired -
US 6180083
Tropane derivatives useable in particular for in vivo detection of dopamine transporters
expired
Frequently asked questions
What is dopamine?
dopamine is a beta-1 adrenergic receptor agonist.